Clinical Pharmacology Intern (Graduate-Level) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 1 week ago

Clinical Pharmacology Intern (Graduate-Level)

AstraZeneca is seeking Master's and PhD students for a 10-week internship role in Clinical Pharmacology. The intern will support exploratory PK/PD and translational analyses, assist with data analysis, and help generate hypotheses regarding dosing schedules.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Support exploratory PK/PD and translational analyses to evaluate dosing schedule optimization for T cell engagers
Review relevant literature, assist with data analysis or modeling, and help generate hypotheses on when less frequent dosing may preserve efficacy and reduce toxicity

Qualification

PKPD modelingClinical pharmacologyData analysisRPythonPublic speakingPresentation designCollaboration

Required

Master's and PhD students studying PKPD modeling, Clinical pharmacology, Pharmaceutical Science, Mathematics, Statistics, or a related discipline
Candidates must have an expected graduation date after August 2026
Knowledge of PK/PD and clinical pharmacology are required
US Work Authorization is required at time of application
Ability to report onsite to Waltham, MA site 3-5 days per week

Preferred

Experience with data analysis/modeling tools such as R or Python preferred
Experience with clinical study is preferred
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase